Zimmer Biomet Q2 net income jumps 29.8% to $198.3M on tariff refunds and lower taxes

Filed August 5, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 7, 2025 · ~1 min read

Key Changes

• high

  Net income rose 29.8% to $198.3M, with diluted EPS up 33.8% to $1.03, helped by a $30M tariff refund and a lower effective tax rate (21.8% vs 31.7%).

  MD&A: Net earnings verify on EDGAR →
• high

  Revenue grew 4.8% to $2.18B, driven by Paragon 28, robotics, and bone cement, but pricing turned negative (-0.8%) and 2026 sales growth guidance was cut to 3.9-4.9%.

  MD&A: Outlook verify on EDGAR →
• high

  The company repurchased $500.8M of stock in H1 2026, more than double the prior year, and replaced its $2B buyback with a new $1.5B program.

  MD&A: Share repurchases verify on EDGAR →